The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Of Georgia Group Regulatory News (BGEO)

Share Price Information for Bank Of Georgia Group (BGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,000.00
Bid: 3,995.00
Ask: 4,005.00
Change: 35.00 (0.88%)
Spread: 10.00 (0.25%)
Open: 3,945.00
High: 4,035.00
Low: 3,920.00
Prev. Close: 3,965.00
BGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BOG raises local currency funding from Symbiotics

21 Feb 2018 07:00

RNS Number : 4916F
Bgeo Group PLC
21 February 2018
 

 

 

 

 

 

London, 21 February 2018

 

JSC Bank of Georgia raises GEL 25 million local currency funding from Symbiotics

BGEO Group PLC (the "Group" or "BGEO"), announces that its banking business subsidiary, JSC Bank of Georgia (the "Bank of Georgia") has signed a loan agreement with Symbiotics ("the Company") - a Swiss investment company active in emerging and frontier economies. The GEL-denominated loan facility, totaling GEL 25 million (US$10 million) and with a maturity of two to three years, will be used to support Georgia's micro, small and medium sized enterprises with their increasing local currency financing needs.

 

 

Kaha Kiknavelidze, Bank CEO commented: "I am pleased that Bank of Georgia continues to actively establish new partnerships with financial institutions in order to secure local currency financial solutions for its clients and further support the de-dollarisation process in the country. This local currency loan agreement is Bank of Georgia's first transaction with Symbiotics, and the first step towards long-term successful co-operation."

 

Daniel Schriber, Director of Investments at Symbiotics noted: "We are very proud to partner with such a reputable and leading financial institution as Bank of Georgia, and glad to support the growth of Georgian micro, small and medium sized enterprises via this local currency loan in the context of the de-dollarisation of the country."

 

 

 

 

 

Name of authorised official of issuer responsible for making notification: Natia Kalandarishvili, Head of Investor Relations and Funding

 

 

About the Symbiotics Group

Symbiotics, incorporated in 2004 in Geneva, is an investment company specialised in emerging, sustainable and inclusive finance which offers market research, investment advisory and asset management services. It is an asset manager of collective investment schemes regulated by FINMA, the Swiss Financial Market Supervisory Authority and has an advisory license from the FCA, the Financial Conduct Authority, through its subsidiary in the UK. The company is headquartered in Geneva, with offices in Cape Town, London, Amsterdam, Zurich, Mexico City, Singapore, with a staff of over 130 professionals. Since 2004, Symbiotics has invested over US$ 4 billion in more than 375 microfinance institutions in 68 emerging countries, working with 44 investment funds and many institutional investors.

 

 

About BGEO Group PLC

The Group: BGEO Group PLC ("BGEO"- LSE: BGEO LN) is a UK incorporated holding company of a Georgia-focused investment platform. BGEO invests, via its subsidiaries, in the banking and non-banking sectors in Georgia (BGEO and its subsidiaries, together the "Group"). BGEO aims to deliver on its strategy of: (1) at least 20% ROAE from its Banking Business; (2) 15%-20% growth of its Banking Business loan book; (3) at least 25% IRR; and (4) up to 20% of the Group's profit from its Investment Business. On 3 July 2017 BGEO announced its intention to demerge BGEO Group PLC into a London-listed banking business (the "Banking Business") and a London-listed investment business (the "Investment Business") by the end of the first half of 2018. 

Banking Business: Currently comprises: a) retail banking and payment services, b) corporate investment banking and wealth management operations and c) banking operations in Belarus ("BNB"). JSC Bank of Georgia ("BOG" or the "Bank") is the core entity of the Group's Banking Business. The Banking Business will continue to target to benefit from the underpenetrated banking sector in Georgia primarily through its retail banking services.

Investment Business: Currently comprises the Group's stakes in Georgia Healthcare Group PLC ("Healthcare Business" or "GHG") - an LSE (a London Stock Exchange) premium-listed company, Georgia Global Utilities ("Utility and Energy Business" or "GGU"), m2 Real Estate ("Real Estate Business" or "m2"), Teliani Valley ("Beverage Business" or "Teliani") and Aldagi ("Property and Casualty Insurance Business" or Aldagi"). Georgia's fast-growing economy provides opportunities in a number of underdeveloped local markets and the Investment Business will target to capture growth opportunities in the Georgian corporate sector.

 

JSC BGEO Group has, as of the date hereof, the following credit ratings:

Bank of Georgia has, as of the date hereof, the following credit ratings:

Fitch Ratings

'BB-/B'

Fitch Ratings

'BB-/B'

Moody's

B1/NP (FC) & B1/NP (LC)

Moody's

'Ba3/NP' (FC) & 'Ba2/NP' (LC)

 

For further information, please visit www.bgeo.com or contact: 

Irakli Gilauri

Michael Oliver

Giorgi Alpaidze

Group CEO

Adviser to the CEO

Group CFO

+995 322 444 109

+44 203 178 4034

+995 322 444 190

igilauri@bgeo.com

moliver@bgeo.com

g.alpaidze@bgeo.com

 

 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKAFASFPEEF
Date   Source Headline
6th Oct 20237:00 amRNSBOGG announces dividend currency conversion rate
22nd Sep 20235:19 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding - Replacement
15th Sep 20232:46 pmRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSDividend Declaration
17th Aug 20237:00 amRNSBOGG PLC announces a share buyback programme
17th Aug 20237:00 amRNSHalf-year Report
11th Aug 20233:08 pmRNSDirector/PDMR Shareholding
7th Aug 20232:11 pmRNSDirector/PDMR Shareholding
2nd Aug 20235:08 pmRNSDirector/PDMR Shareholding
31st Jul 20235:11 pmRNSDirector/PDMR Shareholding
31st Jul 20235:08 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSNotice of Results
24th Jul 20234:29 pmRNSDirector/PDMR Shareholding
24th Jul 20234:27 pmRNSDirector/PDMR Shareholding
18th Jul 20233:50 pmRNSHolding(s) in Company
17th Jul 20233:39 pmRNSDirector/PDMR Shareholding
17th Jul 20233:39 pmRNSDirector/PDMR Shareholding
10th Jul 20234:37 pmRNSDirector/PDMR Shareholding - Clarification
10th Jul 20234:07 pmRNSDirector/PDMR Shareholding
10th Jul 20234:06 pmRNSDirector/PDMR Shareholding
3rd Jul 20235:25 pmRNSDirector/PDMR Shareholding
3rd Jul 202312:50 pmRNSTotal Voting Rights
30th Jun 20237:00 amRNSDividend Declaration
28th Jun 20234:53 pmRNSDirector/PDMR Shareholding
26th Jun 202312:22 pmRNSDirector/PDMR Shareholding
22nd Jun 202312:49 pmRNSCancellation of Treasury Shares
19th Jun 20234:39 pmRNSTransaction in Own Shares
16th Jun 20234:52 pmRNSTransaction in Own Shares
15th Jun 20234:56 pmRNSTransaction in Own Shares
14th Jun 20235:00 pmRNSTransaction in Own Shares
13th Jun 20235:02 pmRNSTransaction in Own Shares
12th Jun 20234:55 pmRNSTransaction in Own Shares
12th Jun 20232:16 pmRNSDirector/PDMR Shareholding
9th Jun 20235:42 pmRNSTransaction in Own Shares
8th Jun 20235:15 pmRNSTransaction in Own Shares
7th Jun 20235:24 pmRNSTransaction in Own Shares
7th Jun 20235:17 pmRNSDirector/PDMR Shareholding
6th Jun 20235:44 pmRNSTransaction in Own Shares
5th Jun 20235:47 pmRNSTransaction in Own Shares
2nd Jun 20235:00 pmRNSTransaction in Own Shares
1st Jun 20234:58 pmRNSTransaction in Own Shares
1st Jun 20232:02 pmRNSTotal Voting Rights
31st May 20235:14 pmRNSTransaction in Own Shares
31st May 20233:04 pmRNSCancellation of Treasury Shares
30th May 20234:57 pmRNSTransaction in Own Shares
30th May 20234:15 pmRNSDirector/PDMR Shareholding
26th May 20235:03 pmRNSTransaction in Own Shares
26th May 20233:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.